Apport de l'imagerie par tomographie a emission de positons dans la pathologie pleurale. Interet de la TEP en pathologie pleurale.

Duysinx, Bernard; Corhay, Jean-Louis; Larock, Marie-Paule; Withofs, Nadia; Bury, Thierry; Hustinx, Roland; Louis, Renaud

doi:10.1016/S0761-8425(08)71511-0

Article (Scientific journals)

Apport de l'imagerie par tomographie a emission de positons dans la pathologie pleurale. Interet de la TEP en pathologie pleurale.

Duysinx, Bernard; Corhay, Jean-Louis; Larock, Marie-Paule et al.

2008 • In Revue des Maladies Respiratoires, 25 (2), p. 129-38

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/5388

DOI
10.1016/S0761-8425(08)71511-0

PubMed
18449075

Files (2)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Apport de l_imagerie par tomographie_Duysinx_08_RevMalRespi.pdf

Author postprint (383.07 kB)

Download

Full Text Parts

Apport de l’imagerie par tomographie_Duysinx_08_RevMalRespi.pdf

Publisher postprint (383.69 kB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Positron emission tomography; Pleurisy; Pleural mesothelioma; Pleural metastases; Lung cancer

Abstract :

[en] INTRODUCTION: Positron emission tomography (PET) has a clear role in oncology, particularly in thoracic disease. In the light of our experience and a revue of the literature we define precisely the role of metabolic imaging in the diagnosis of pleural pathology. BACKGROUND: In particular PET allows characterisation of malignant pleural disease and provides prognostic information in mesothelioma. Metabolic imaging provides clinical information for the staging of pulmonary cancer, in the search for a primary tumour in metastatic pleurisy and also in the follow up of chronic or recurrent pleural pathology. CONCLUSIONS: It is justified, therefore, that PET joins the diagnostic armamentarium of pleural pathology, solid or liquid.

Disciplines :

Cardiovascular & respiratory systems

Author, co-author :

Duysinx, Bernard ; Université de Liège - ULiège > Pneumologie-Allergologie

Corhay, Jean-Louis ; Centre Hospitalier Universitaire de Liège - CHU > Pneumologie-Allergologie

Larock, Marie-Paule; Centre Hospitalier Universitaire de Liège - CHU > Médecine Nucléaire

Withofs, Nadia ; Centre Hospitalier Universitaire de Liège - CHU > Médecine nucléaire

Bury, Thierry ; Centre Hospitalier Universitaire de Liège - CHU > Pneumologie-Allergologie

Hustinx, Roland ; Centre Hospitalier Universitaire de Liège - CHU > Médecine nucléaire

Louis, Renaud ; Université de Liège - ULiège > Département des sciences cliniques > Pneumologie - Allergologie

Language :

French

Title :

Apport de l'imagerie par tomographie a emission de positons dans la pathologie pleurale. Interet de la TEP en pathologie pleurale.

Alternative titles :

[en] The contribution of positron emission tomography in pleural disease

Publication date :

2008

Journal title :

Revue des Maladies Respiratoires

ISSN :

0761-8425

eISSN :

1776-2588

Publisher :

Masson, Moulineaux Cedex 9, France

Volume :

Issue :

Pages :

129-38

Peer reviewed :

Peer Reviewed verified by ORBi

Additional URL :

http://www.sciencedirect.com/science?_ob=PublicationURL&_tockey=%23TOC%2343627%232008%23999749997%23692419%23FLP%23&_cdi=43627&_pubType=J&_auth=y&_acct=C000026659&_version=1&_urlVersion=0&_userid=532038&md5=3647b5f2833ecf58d6144fec91b4218f

Available on ORBi :

since 02 February 2009

Statistics

Number of views

136 (20 by ULiège)

Number of downloads

363 (9 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Leung A, Muller N, Miller R : CT in differential diagnosis of diffuse pleural disease. Am J Roentgenol 1990 ; 154 : 487-92.
Dedrick CG, McLoud TC, Shepard JA, Shipley RT : Computed tomography of localized pleural mesothelioma. Am J Roentgenol 1985 ; 144 : 275-80.
Light RW, Macgregor MI, Luchsinger PC, Ball WC : Pleural effusions: the diagnositic of transudates and exsudates. Ann Intern Med 1972 ; 77 : 507-13.
Light RW, Erozan YS, Ball WC : Cells in pleural fluid. Their value in differential diagnosis. Arch Intern Med 1973 ; 132 : 854-60.
Schönfeld N, Loddenkemper R : Pleural biopsy and thoracoscopy. Eur Respi Mon 1998 ; 9 : 135-52.
Prakash U, Reiman H : Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases. Mayo Clin Proc 1985 ; 60 : 158-64.
Von Hoff D, Di Volsi V : Diagnostic reliability of needle biopsy of the parietal pleura: a review of 272 biopsies. Am J Clin Pathol 1979 ; 72 : 48-51.
Boutin C, Viallat J-R, Rey F : Manuel pratique des techniques pleurales. Springer-Verlag France 1991, 59-63.
Sahn S : Malignant pleural effusions. Eur Respir Monograph 2002 ; 22 : 177-88.
Antunes G, Neville E, Duffy J, on behalf of the BTS Pleural Disease Group, a subgroup of the BTS Stabdards of Care Committe : BTS guidelines for the management of malignant pleural effusions. Thorax 2003 ; 58 : ii29-ii38.
Sahn S : Malignant pleural effusions. In : Fischman AP, ed. Pulmonary diseases and disorders 2nd ed. New York : Mc Graw-Hill, 1988 : 2159-70.
Bury T, Daenen F, Duysinx B, Bartsch P, Corhay JL : Applications en oncologie thoracique de la TEP-18 FDG. Rev Mal Respir 2001 ; 18 : 623-30.
Vansteenkiste JF : Imaging in lung cancer: positron emission tomography scan. Eur Respir J 2002 ; 35 : S49-60.
Bury T, Duysinx B, Corhay JL, Bartsch P, Rigo P :Comment j’explore un cancer broncho-pulmonaire par imagerie métabolique (TEP-18-FDG). Rev Med Liege 2000 ; 55 : 178-83.
La Tomographie à émission de positons (TEP). In : Standards Options et Recommandations : le cancer bronchopulmonaire non à petites cellules. John Libbey Eurotext 2002 : 86-8.
Bury T, Dowlati A, Paulus P, Corhay JL, Benoit T, Kayembe JM, Limet R, Rigo P, Radermecker M: Evaluation of the solitary pulmonary nodule by positron emission tomography imaging. Eur Respir J 1996 ; 9 : 410-4.
Bury T, Paulus P, Dowlati A, Corhay JL, Weber T, Ghaye B, Schoffers J, Limet R, Albert A, Rigo P, Radermecker M : Staging of the mediastinum: value of positron emission tomography imaging in non-small cell lung cancer. Eur Respir J 1996 ; 9 : 2560-4.
Vaylet F, Bonardel G, Salles Y, Bonnichon A, Gontier E, Margery J, Mantzarides M, Guigay J, Foehrenbach H : La tomographie par émission de positons au 18fluoro-deoxy-glucose (18FDG-TEP) et le bilan initial du cancer brocnhique. Rev Mal Respir 2005 ; 22 : 8S43-8.
Hustinx R, Paulus P, Jacquet N, Jerusalem G, Bury T, Rigo P : Clinical evaluation of whole-body 18F-fluorodeoxyglucose positron emission tomography in the detection of liver metastases. Ann Oncol 1998 ; 9 : 397-401.
Bury T, Barreto A, Daenen F, Barthelemy N, Ghaye B, Rigo P : Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer. Eur J Nucl Med 1998 ; 25 : 1244-7.
Bury T, Corhay JL, Duysinx B, Daenen F, Ghaye B, Barthelemy N, Rigo P, Bartsch P : Value of FDG-PET in detecting residual or recurrent nonsmall cell lung cancer. Eur Respir J 1999 ; 14 : 1376-80.
Meignan M, Paone G : La tomographie par émission de positons (TEP) au 18- fluoro-déoxy-glucose (18FDG) dans l’évaluation de la pathologie pleurale maligne. Rev Pneumol Clin 2006 ; 62 : 128-34.
Bénard F, Sterman D, Smith RJ, Kaiser LR, Albelda SM, Alavi A : Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography. Chest 1998 ; 114 : 713-22.
Duysinx B, Nguyen D, Louis R, Cataldo D, Belhocine T, Bartsch P, Bury T : Evaluation of pleural disease with 18-Fluorodeoxyglucose Positron Emission Tomography imaging. Chest 2004 ; 125 : 489-93.
Kramer H, Pieterman RM, Slebos DJ, Timens W, Vaalburg W, Koëter GH, Groen HJ : PET for evaluation of pleural thickening observed on CT. J Nucl Med 2004 ; 45 : 995-8.
Schaffler GJ, Wolf G, Schoellnast H, Groell R, Maier A, Smolle-Jüttner FM, Woltsche M, Fasching G, Nicoletti R, Aigner RM : Non-small cell lung cancer: evaluation of pleural abnomalies on CT scans with 18F FDG PET. Radiology 2004 ; 231 : 858-65.
Carretta A, Landoni C, Melloni G, Ceresoli GL, Compierchio A, Fazio F, Zannini P : 18-FDG-positron emission tomography in the evaluation of malignant pleural dieases- a pilot study. Eur J of Cardio-thorac Surg 2000 ; 17 : 377-83.
Erasmus JJ, McAdams HP, Rossi SE, Goodman PC, Coleman RE, Patz EF : FDG PET of pleural effusions in patients with non-small cell lung cancer. AJR Am J Roent 2000 ; 175 : 245-9.
Gupta NC, Rogers JS, Graeber GM, Gregory JL, Waheed U, Mullet D, Atkins M : Clinical role of F-18 Fluorodeoxyglucose Positron Emission Tomography Imaging in Patients with lung cancer and suspected malignant pleural effusion. Chest 2002 ; 122 : 1918-24.
Bury T, Paulus P, Dowlati A, Corhay JL, Rigo P, Radermecker MF : Evaluation of pleural disease with FDG-PET imaging: preliminary report. Thorax 1997 ; 52 : 187-9.
Toaff JS, Metser U, Gottfried M, Gur O, Deeb ME, Lievshitz G, Mercer D, Even-Sapir E : Differentiation between malignant and benign pleural effusion in patients with extra-pleural primary malignancies. Assessment with positron emission tomography-computed tomography. Investigative Radiology 2005 ; 40 : 204-9.
Balogova S, Grahek D, Kerrou K, Montravers F, Younsi N, Aide N, Jacob T, Talbot JN : L’imagerie nucléaire au 18FDG dans les lésions pleurales en apparence isolées. Rev Pneumol Clin 2003 ; 59 : 275-88.
Duysinx B, Larock MP, Nguyen D, Corhay JL, Bury T, Hustinx R, Louis R : 18F-FDG PET imaging in assessing exudative pleural effusions. Nucl Med Commun 2006 ; 27 : 971-6.
Menda Y, Bushnell DL, Madsen MT, McLaughlin K, Kahn D, Kernstine KH : Evaluation of various corrections to the standardized uptake value for diagnosis of pulmonary malignancy. Nucl Med Com 2001 ; 22 : 1077-981.
Vansteenkiste JF, Stroobants SG, Dupont PJ, De Leyn PR, Verbeken EK, Deneffe GJ, Mortelmans LA, Demedts MG : Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: An analysis of 125 cases. Leuven Lung Cancer Group. J Clin Oncol 1999 ; 17 : 3201-6.
Dhital K, Saunders CA, Seed PT, O’Doherty MJ, Dussek J : [(18)F]Fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer. Eur J Cardiothorac Surg 2000 ; 18 : 425-8.
Higashi K, Ueda Y, Ayabe K, Sakurai A, Seki H, Nambu Y, Oguchi M, Shikata H, Taki S, Tonami H, Katsuda S, Yamamoto I : FDG PET in the evaluation of the aggressiveness of pulmonary adenocarcinoma: correlation with histopathological features. Nucl Med Commun 2000 ; 21 : 707-14.
Bénard F, Sterman D, Smith RJ, Kaiser LR, Albelda SM, Alavi A : Pronostic value of 18F-FDG PET imaging in malignant pleural mesothelioma. J Nucl Med 2000 ; 41 : 1443-4.
Flores RM, Akhurst T, Gonen M, Zakowski M, Dycoco J, Larson SM, Rusch VW : Positron émission tomography predicts survival in malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2006 ; 132 : 763-8.
Trail ZC, Davis Rj, Gleeson FV : Thoracic computed tomography in patients with suspected malignant pleural effusions. Clin Radiol 2001 ; 56 : 193-6.
Dwamena BA, Sonnad SS, Angobaldo JO, Wahl RL : Metastases from non-small cell lung cancer: mediastinal staging in the 1990s- a meta-analytical comparaison of PET and CT. Radiology 1999 ; 213 : 530-6.
Kole AC, Nieweg OE, Pruim J, Hoekstra HJ, Koops HS, Roodenburg JL, Vaalburg W, Vermey A : Detection of unknown occult primary tumors using positron emission tomography. Cancer 1998 ; 82 : 1160-6.
Bohuslavizki KH, Klutmann S, Kröger S, Sonnemann U, Buchert R, Werner JA, Mester J, Clausen M : FDG PET detection of unknown primary tumors. J Nucl Med 2000 ; 41 : 816-22.
Alberini JL, Belhocine T, Hustinx R, Daenen F, Rigo P : Whole-body positron emission tomography using fluorodeoxyglucose in patients with metastases of unknown primary tumors (CUP syndrome). Nucl Med Commun 2003 ; 24 : 1081-6.
Mantaka P, Baum RP, Hertel A, Adams S, Niessen A, Sengupta S, Hör G : PET with 2-[F-18]-fluoro-2-deoxy-D-glucose (FDG) in patients with cancer of unknown primary (CUP): influence on patients’ diagnostic and therapeutic management. Cancer Biother Radiopharm 2003 ; 18 : 47-58.
Rades D, Kühnel G, Wildfang I, Börner AR, Schmoll HJ, Knapp W : Localised disease in cancer of unknown primary (CUP): the value of positron emission tomography (PET) for individueal therapeutic management. Ann Oncol 2001 ; 12 : 1605-9.
Melloni B, Monteil J, Vincent F, Bertin F, Gaillard S, Ducloux T, Verbeke S, Maubon A, Vandroux JC, Bonnaud F : Assessment of 18F-fluorodeoxyglucose dual-head gamma camera in asbestos lung diseases. Eur Respir J 2004 ; 24 : 814-21.
Dresler CM, Olak J, Herndon JE, Richards WG, Scalzetti E, Fleishman SB, Kernstine KH, Demmy T, Jablons DM, Kohman L, Daniel TM, Haasler GB, Sugarbaker DJ ; Cooperative Groups Cancer and Leukemia Group B ; Eastern Cooperative Oncology Group ; North Central Cooperative Oncology Group ; Radiation Therapy Oncology Group: Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest 2005 ; 127 : 909-15.
Weiss N, Solomon S : Talc pleurodesis mimics pleural metastases. Differentiation with positron emission tomography/computed tomography. Clin Nucl Med 2003 ; 28 : 801-14.
Kwek B, Aquino S, Fischman A : Fluorodeoxyglucose positron emission tomography and CT after talc pleurodesis. Chest 2004 ; 125 : 2356-60.